148 related articles for article (PubMed ID: 36751445)
1. Traumatic scalp arteriovenous fistula post capillary implantation successfully treated using PHIL embolic agent.
Alfaro AJQ; Ortíz AFH; Mejia JA; Ortegon JDC; Gutierrez LC; Tovar CAD; Zarate M; Gil-Quiñones SR; Montañez MYB; Beaujon LF; Daza OMD
Surg Neurol Int; 2023; 14():12. PubMed ID: 36751445
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
Vollherbst DF; Otto R; von Deimling A; Pfaff J; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
J Neurointerv Surg; 2018 Mar; 10(3):268-274. PubMed ID: 28689184
[TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
Leyon JJ; Chavda S; Thomas A; Lamin S
J Neurointerv Surg; 2016 Jun; 8(6):596-602. PubMed ID: 25994938
[TBL] [Abstract][Full Text] [Related]
4. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
Lamin S; Chew HS; Chavda S; Thomas A; Piano M; Quilici L; Pero G; Holtmannspolter M; Cronqvist ME; Casasco A; Guimaraens L; Paul L; Gil Garcia A; Aleu A; Chapot R
AJNR Am J Neuroradiol; 2017 Jan; 38(1):127-131. PubMed ID: 27932510
[TBL] [Abstract][Full Text] [Related]
5. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
Vollherbst DF; Sommer CM; Ulfert C; Pfaff J; Bendszus M; Möhlenbruch MA
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1377-1382. PubMed ID: 28522669
[TBL] [Abstract][Full Text] [Related]
6. Endovascular embolization of canine hepatic arteriovenous malformations using precipitating hydrophobic injectable liquid (PHIL) liquid embolic agent: a proof of concept study.
Ryan SD; Nambiar A; Maingard J; Kok HK; Turner RBS; Brooks DM; Asadi H
CVIR Endovasc; 2019 Aug; 2(1):27. PubMed ID: 32026126
[TBL] [Abstract][Full Text] [Related]
7. Absence of skin discoloration after transarterial embolization of a subcutaneous auricular arteriovenous malformation with PHIL.
In 't Veld M; Willems PW
Interv Neuroradiol; 2016 Oct; 22(5):606-10. PubMed ID: 27298010
[TBL] [Abstract][Full Text] [Related]
8. Endovascular treatment for traumatic scalp arteriovenous fistulas: results with Onyx embolization.
Dabus G; Pizzolato R; Lin E; Kreusch A; Linfante I
J Neurointerv Surg; 2014 Jun; 6(5):405-8. PubMed ID: 23788364
[TBL] [Abstract][Full Text] [Related]
9. Successful Endovascular Treatment of a Traumatic Cervical Arteriovenous Fistula After a Carotid Paraganglioma Resection: A Case Report.
Quiroz Alfaro AJ; Herrera Ortíz AF; Diaz OM; Hidalgo J; Hakim Tawil JA; Cardona Ortegón JD; Mejía JA
Cureus; 2023 Apr; 15(4):e38284. PubMed ID: 37255885
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Type II Endoleaks with a Novel Agent: Precipitating Hydrophobic Injectable Liquid (PHIL).
Helmy A; Shaida N
Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1094-1098. PubMed ID: 28194506
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs.
Samaniego EA; Kalousek V; Abdo G; Ortega-Gutierrez S
J Neurointerv Surg; 2016 Dec; 8(12):1253-1255. PubMed ID: 26819446
[TBL] [Abstract][Full Text] [Related]
12. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL
Giurazza F; Corvino F; Silvestre M; Cangiano G; De Magistris G; Cavaglià E; Amodio F; Niola R
Radiol Med; 2021 Mar; 126(3):474-483. PubMed ID: 32889705
[TBL] [Abstract][Full Text] [Related]
13. Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report.
Kurda D; Guduguntla G; Maingard J; Kok HK; Lalloo S
CVIR Endovasc; 2019 May; 2(1):17. PubMed ID: 32026176
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations.
Sirakov SS; Sirakov A; Minkin K; Hristov H; Ninov K; Penkov M; Karakostov V; Orlov K; Gorbatykh A; Kislitsin D; Raychev R
Interv Neuroradiol; 2019 Feb; 25(1):58-65. PubMed ID: 30223686
[TBL] [Abstract][Full Text] [Related]
15. PHIL and Squid Embolization of Cerebral Arteriovenous Malformation: A Retrospective Case Series of 23 Patients.
Cheung EYH; Ng RYT; Yu SCH; Zhuang JTF; Wong GKC
Neurointervention; 2022 Nov; 17(3):174-182. PubMed ID: 36039561
[TBL] [Abstract][Full Text] [Related]
16. Precipitating hydrophobic injectable liquid embolization of intracranial vascular shunts: initial experience and technical note.
Varadharajan S; Ramalingaiah AH; Saini J; Gupta AK; Devi BI; Acharya UV
J Neurosurg; 2018 Nov; 129(5):1217-1222. PubMed ID: 29192863
[TBL] [Abstract][Full Text] [Related]
17. Novel use of precipitating hydrophobic injectable liquid (PHIL) in pre-operative angioembolisation of a large posterior auricular arteriovenous malformation.
Chu C; Tan THL; Ng KS; Tan CS; Lee TS; Yuen HW; Lee W; Huang XY
Am J Otolaryngol; 2023; 44(2):103786. PubMed ID: 36680841
[TBL] [Abstract][Full Text] [Related]
18. Onyx removal after embolization of a superior sagittal sinus dural arteriovenous fistula involving scalp artery.
Watanabe J; Maruya J; Nishimaki K; Ito Y
Surg Neurol Int; 2016; 7(Suppl 14):S410-4. PubMed ID: 27313969
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a New Version of the Liquid Embolic Agent PHIL with Extra-Low-Viscosity in an Endovascular Embolization Model.
Vollherbst DF; Otto R; Hantz M; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1696-1702. PubMed ID: 30093480
[TBL] [Abstract][Full Text] [Related]
20. Endovascular and percutaneous embolization of a giant post traumatic arteriovenous fistula of inferior epigastric vessels.
Arunachalam VS; Sharma S; Valakkada J; Ayyappan A; Radhakrishnan J; Kannath SK
CVIR Endovasc; 2024 May; 7(1):43. PubMed ID: 38709345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
